Clinical Outcomes and Self-Reported Symptoms in Patients With Acromegaly: An 8-Year Follow-Up of a Lanreotide Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Outcomes and Self-Reported Symptoms in Patients With Acromegaly: An 8-Year Follow-Up of a Lanreotide Study

Published:2017-01 Issue:1 Volume:23 Page:56-65
ISSN:1530-891X
Container-title:Endocrine Practice
language:en
Short-container-title:Endocrine Practice

Author:

Khairi Shafaq,Sagvand Babak Torabi,Pulaski-Liebert Karen J.,Tritos Nicholas A.,Klibanski Anne,Nachtigall Lisa B.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference21 articles.

1. GH/IGF-I normalization and tumor shrinkage during longterm treatment of acromegaly by lanreotide;Attanasio;J Endocrinol Invest,2014

2. Long-term safety and efficacy of depot long-acting somatostatin analogs for the treatment of acromegaly;Ayuk;J Clin Endocrinol Metab,2002

3. Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa;Maiza;Clin Endocrinol (Oxf),2007

4. Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegaly;Caron;Clin Endocrinol (Oxf),2006

5. Four-year follow-up of acromegalic patients treated with the new long-acting formulation of Lanreotide (Lanreotide Autogel);Gutt;Exp Clin Endocrinol Diabetes,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New opportunities for secondary drug therapy of acromegaly;Meditsinskiy sovet = Medical Council;2020-05-29

2. Modern methods of medical treatment of acromegaly;Medical Council;2020-01-28

3. Quality of life is significantly impaired in both secretory and non‐functioning pituitary adenomas;Clinical Endocrinology;2018-12-12

4. How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review;Pituitary;2018-03-31

5. Lanreotide Therapy in Carcinoid Syndrome: Prospective Analysis of Patient-Reported Symptoms in Patients Responsive To Prior Octreotide Therapy And Patients Naïve To Somatostatin Analogue Therapy in The Elect Phase 3 Study;Endocrine Practice;2018-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3